This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
RBC Cuts Price Target on AdaptHealth to $11 From $13, Keeps Outperform Rating Nov. 19 MT
Truist Lowers Price Target on AdaptHealth to $12 From $13, Maintains Buy Rating Nov. 15 MT
UBS Adjusts Price Target on AdaptHealth to $12 From $13, Maintains Buy Rating Nov. 06 MT
Correction: AdaptHealth Swings to Q3 Earnings, Revenue Increases; Fiscal 2024 Revenue Guidance Lowered Nov. 05 MT
AdaptHealth Swings to Q3 Earnings, Revenue Increases; Fiscal 2024 Revenue Guidance Lowered Nov. 05 MT
Earnings Flash (AHCO) ADAPTHEALTH Reports Q3 Revenue $805.9M Nov. 05 MT
AdaptHealth Appoints Scott Barnhart as Chief Operating Officer Aug. 26 MT
AdaptHealth to Transition Chief Operating Officer to Chief Business Officer Role Aug. 19 MT
Deutsche Bank Trims AdaptHealth Price Target to $9.50 From $10, Maintains Hold Rating Aug. 07 MT
Sector Update: Health Care Stocks Rise Late Afternoon Aug. 06 MT
Sector Update: Health Care Stocks Rise in Afternoon Trading Aug. 06 MT
AdaptHealth Shares Fall After Company's Q2 Earnings Trail Analysts' Estimates Aug. 06 MT
Earnings Flash (AHCO) ADAPTHEALTH Posts Q2 Revenue $806M, vs. Street Est of $802.6M Aug. 06 MT
Earnings Flash (AHCO) ADAPTHEALTH Posts Q2 Revenue $806M, vs. Street Est of $802.6M Aug. 06 MT
AdaptHealth Appoints Dale Wolf as Board Chair, President Josh Parnes Stepping Down in August Jul. 03 MT
AdaptHealth's Shares Fall After Q1 Net Loss Misses Analysts' Forecast May. 07 MT
Earnings Flash (AHCO) ADAPTHEALTH Reports Q1 Revenue $792.5M, vs. Street Est of $769.9M May. 07 MT
AdaptHealth Names Suzanne Foster as CEO Apr. 17 MT
UBS Adjusts AdaptHealth Price Target to $13 From $9, Maintains Buy Rating Feb. 28 MT
Deutsche Bank Adjusts AdaptHealth Price Target to $10 From $8, Maintains Hold Rating Feb. 28 MT
AdaptHealth's Q4 Loss Widens, Revenue Rises; Provides 2024 Revenue Guidance; Shares Climb Feb. 27 MT
Earnings Flash (AHCO) ADAPTHEALTH Posts Q4 Revenue $858.2M, vs. Street Est of $825.5M Feb. 27 MT
UBS Trims AdaptHealth Price Target to $9 From $10, Maintains Buy Rating Jan. 29 MT
UBS Adjusts AdaptHealth Price Target to $10 From $18, Maintains Buy Rating Nov. 08 MT
BofA Securities Downgrades AdaptHealth to Underperform From Neutral, Adjusts Price Target to $6.50 From $9.50 Nov. 08 MT
Chart DFB Healthcare Acquisitions Corp.
AHCO: Dynamic Chart
  1. Stock Market
  2. Equities
  3. AHCO Stock
  4. News DFB Healthcare Acquisitions Corp.
  5. AdaptHealth to Replace Meritor in S&P SmallCap 600